Intrinsic Imaging
Intrinsic Imaging radiologist reviewing brain MRI scans in the reading room

ISO Certified Imaging Core Lab

Intrinsic Imaging holds five certifications from the British Standards Institution (BSI), specifically for the provision of imaging core lab services for clinical trials: ISO 9001, ISO 13485, ISO 22301, ISO/IEC 27001 and ISO/IEC 27018. Together, they address quality management, medical device quality requirements, business continuity, information security and the protection of personal information processed in public-cloud environments.

Intrinsic Imaging's quality management system governs how clinical trial images are acquired, reviewed and translated into imaging assessments. It brings documented procedures, qualified personnel and controlled technology into a common operating framework, so that the evidence supporting an endpoint can be examined from the source image through the final data transfer.

Clinical interpretation alone cannot establish the integrity of an imaging endpoint. Acquisition methods, reader qualification, blinding, data handling and the management of deviations each influence the assessment. Intrinsic Imaging's approach to integrated quality management systems connects these responsibilities rather than treating quality, information security and operational continuity as separate concerns.

This framework supports Intrinsic Imaging's Phase I–IV pharmaceutical and biotechnology trials, Class I–III medical device studies and AI/CAD clinical validation programs. Its practical value lies in the application of the standards to the study: specifying how imaging work will be performed, retaining evidence of its execution and controlling changes that could affect the interpretation or integrity of the data.

Certification Scope and Independent Oversight

  • Intrinsic Imaging is the only imaging core lab in the world to hold five BSI ISO certifications specifically for providing imaging core lab services for clinical trials. The certification scope concerns those services, not a sponsor's investigational product.
  • The British Standards Institution (BSI) certifies Intrinsic Imaging to five complementary standards, each addressing a distinct aspect of the imaging workstream.

    • ISO 9001 establishes the quality management framework for defined processes, competent personnel and continual improvement.
    • ISO 13485 applies medical device quality management requirements to Intrinsic Imaging's clinical trial imaging services.
    • ISO 22301 addresses the preparation, response and recovery arrangements for critical imaging operations.
    • ISO/IEC 27001 provides the management framework for protecting the confidentiality, integrity and availability of information.
    • ISO/IEC 27018 extends information-security controls to the protection of personally identifiable information in public-cloud environments.
  • Intrinsic Imaging first implemented its quality management system in 2011. Its continuing application encompasses study procedures, personnel competence, documentation and the review of process performance.
  • Intrinsic Imaging has completed three FDA inspections spanning medical device and pharmaceutical clinical trials, each with zero Form FDA 483 observations. The FDA inspection record provides the dates, inspection details and outcomes for each inspection.

The Role of Each Standard in Clinical Trial Imaging

StandardScopeApplication to clinical trial imaging
ISO 9001Quality management systemsIntrinsic Imaging defines and controls the processes that produce imaging assessments, from charter development through data delivery. Personnel qualification, process monitoring and corrective action provide a documented basis for evaluating whether the work was performed as intended.
ISO 13485QMS for medical device trialsIntrinsic Imaging applies medical device quality management requirements to the imaging evidence generated in Class I–III medical device trials and AI/CAD clinical validation programs. Documented methods, qualified readers and traceable records support the evaluation of that evidence; certification does not approve the medical device.
ISO 22301Business continuity managementIntrinsic Imaging identifies critical imaging activities and establishes continuity and recovery arrangements for disruption. These controls address the dependencies behind image receipt, quality control and independent review, supporting planned responses rather than relying on improvised recovery.
ISO/IEC 27001Information security managementIntrinsic Imaging manages information-security risks across its imaging core lab services and imaging CRO operations. Access restrictions and controlled information handling protect sponsor data, imaging records and trial results while supporting their integrity and availability.
ISO/IEC 27018Personally identifiable information on the cloudIntrinsic Imaging applies privacy safeguards to personally identifiable information processed in public-cloud environments. Controls over the handling of imaging records address the personal information that may accompany images received from clinical sites.

Quality Management Across the Imaging Lifecycle

Intrinsic Imaging establishes the imaging methodology before routine study imaging begins. The protocol and imaging charter define acquisition requirements, assessment criteria, reader responsibilities and adjudication rules. Site qualification and training translate those requirements into the examinations submitted for review, while study-specific reader preparation establishes how the resulting images will be assessed.

During execution, image quality control and documented queries address completeness, technical suitability and departures from the charter. Blinded independent central review, quantitative analysis and adjudication follow the study's defined methodology. Assessment records and version history preserve the relationship between the images, the clinical interpretation and any subsequent resolution of reader disagreement.

Imaging data management carries that record through reconciliation, database lock and final transfer. Controlled data specifications and review of release readiness help establish what each delivered result represents. The accompanying documentation gives sponsors a basis for examining the imaging workstream and addressing questions about how an endpoint was acquired, assessed and delivered.

BSI ISO certifications: 9001, 13485, 22301, 27001, 27018

Study-Specific Application and Sponsor Oversight

Certification provides a framework for evaluating Intrinsic Imaging's management systems; study documentation shows how that framework is applied to a particular imaging program. The imaging charter and operating plan connect the clinical requirements of the protocol with the procedures, responsibilities and records needed to execute it.

Controlled Technology and Information Governance

Intrinsic Imaging's quality and information-security controls operate together where the imaging record is created, assessed and transferred. Reader access and blinding, assessment forms, query resolution and version history must reflect the study's requirements. Privacy and continuity arrangements address different risks within that same workflow: how personal information is handled and how critical activities are sustained or recovered during disruption.

Computerized-system validation remains a distinct lifecycle responsibility. Intrinsic Imaging applies a risk-based approach to intended use, configured requirements, verification and controlled change. GAMP 5 provides good-practice guidance for that work; it is not an additional certification, and the five ISO certifications do not replace study-specific validation. Intrinsic Imaging's software validation approach describes the relationship between validation evidence, guidance and applicable regulatory requirements.

Evidence for Sponsor Due Diligence

Sponsors can request Intrinsic Imaging's certification documentation and discuss the audit requirements of a proposed study. Certificate scope can be considered alongside relevant procedures, training records, change controls and continuity arrangements, allowing the assessment to focus on the services and risks that matter to the imaging program.

Independent certification and the FDA inspection history provide different forms of oversight. Neither substitutes for the sponsor's evaluation of study-specific methods and records, and neither confers regulatory approval on a sponsor's drug, medical device or AI product. Intrinsic Imaging's role is to provide controlled imaging services and the documentation needed to examine their execution.

Frequently Asked Questions

Should I include participant information in an inquiry to Intrinsic Imaging?
No. Please do not include participant-identifiable data in an initial inquiry to Intrinsic Imaging. Confidential study materials can be shared through an agreed secure process.
When should sponsors engage Intrinsic Imaging in study planning?
Sponsors should ideally engage Intrinsic Imaging before finalizing the protocol and imaging schedule. Early scientific and operational review clarifies acquisition requirements, endpoint feasibility and central-reading dependencies. Intrinsic Imaging can also assume responsibility for an active study through a controlled transfer.
Does Intrinsic Imaging support therapeutic areas beyond its six divisions?
Yes. Beyond Cardiovascular & Thoracic, Central Nervous System, Gastroenterology & Metabolic, Musculoskeletal, Oncology and Ophthalmology, Intrinsic Imaging makes subspecialty radiologists available across every therapeutic area.
Go to more Frequently Asked Questions

Tell us about your trial.

Our team will respond within one business day.